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Abstract
We previously reported that global deletion of insulin receptor substrate protein 1 (Irs1) extends lifespan and increases
resistance to several age-related pathologies in female mice. However, no effect on lifespan was observed in male Irs1 null
mice. We suggested at the time that the lack of any effect in males might have been due to a sample size issue. While such
lifespan studies are essential to our understanding of the aging process, they are generally based on survival curves derived
from single experiments, primarily due to time and economic constraints. Consequently, the robustness of such findings as
a basis for further investigation has been questioned. We have therefore measured lifespan in a second, separate cohort of
Irs1 null female mice, and show that, consistent with our previous finding, global deletion of Irs1 significantly extends
lifespan in female mice. In addition, an augmented and completed study demonstrates lifespan extension in male Irs1 null
mice. Therefore, we show that reduced IRS1-dependent signalling is a robust mechanism through which mammalian
lifespan can be modulated.
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Introduction
The precise mechanisms underlying the aging process in
multicellular organisms are currently unknown. However, the
insulin/insulin-like growth factor-1 (IGF-1) signalling (IIS) path-
way and mammalian target of rapamycin (mTOR) signalling
pathway are highly conserved candidates for protection against the
effects of the ageing process [1,2,3,4,5,6]. Reduced IIS extends
lifespan in both invertebrate and vertebrate model organisms
[2,3,7]. In addition, extended lifespan in growth hormone (GH)/
GH-receptor deficient dwarf mice may act through IIS attenua-
tion [8], and polymorphisms in several IIS and GH-related genes
have been shown to correlate with human lifespan [9,10,11].
Recently, we reported that global deletion of insulin receptor
substrate protein 1 (Irs1), a key downstream mediator of IIS,
increased lifespan in female mice relative to wild type (WT) controls
[12]. In addition, we demonstrated that this long life was
accompanied by a resistance to several age-related pathologies
including skin, bone and motor dysfunction and protection against
age-related glucose intolerance [12]. However, no difference was
reported in male Irs1 null (Irs12/2) mice compared to wild-type
(WT) controls. In our earlier paper [12] we suggested that this lack
of a lifespan effect in males may be partly explained by the relatively
small number of male Irs12/2mice used (n= 10), and/or by the fact
that 3 individuals from this group were still alive at the time of
publication. Interestingly, despite our previously reported lack of
any lifespan effect in male Irs12/2 mice, these animals, like females
Irs12/2 mice, were protected against late life pathologies including
complete protection against the ulcerative dermatitis seen in aged
male WT controls [12]. Male Irs12/2 mice also were protected
against an age-associated alteration in T cell populations (increase in
memory T cells, decrease in naive T cells) [12].
As the majority of IIS mutant mouse aging studies are based on
lifespan curves derived from single experimental cohorts, several
authors (e.g. [13,14]) have suggested that replication and
validation of these experiments is necessary in order to use these
models with confidence in our quest to understand the aging
process. Indeed, significant effort and resources may be wasted if
any model subsequently shows no repeatable retardation in aging.
Ladiges et al. [14] recently reported that only 3 (Ames (Prop1df/df),
Snell (Pit1dw/dw), growth hormone receptor knockout (GHR-KO))
out of 20 published long-lived mouse models showed consistent
lifespan extension across separate studies. In pure IIS mutants the
situation appears more ambiguous, as mice heterozygous for a null
allele of insulin receptor substrate protein 2 (Irs2) were reported as
being long-lived [15], but this finding was not replicated in a
second study [16]. The reasons for this discrepancy between these
two studies are currently unclear [16], but may be due to an
atypical WT survival curve in the earlier study [15].
In the current study we examined lifespan in a second,
independent cohort of female WT and Irs12/2 mice to determine
whether our original finding was indeed repeatable. In addition,
we present data from our completed male lifespan study which has
been further augmented by 2 additional WT and 2 additional
Irs12/2 littermates that were not included in the original study,
but were derived from the same group of breeders as that of our
original study.
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Results and Discussion
In agreement with our previous study [12], median lifespan was
significantly increased (Log rank X2= 4.916, P,0.05) in female
Irs12/2 mice relative to WT controls (Fig. 1A (indicated by solid
lines), Table 1). No difference in lifespan was observed within each
genotype (i.e. WT vs. WT; Irs12/2 vs. Irs12/2) between the
current study and our original study [12] (Fig. 1A; WT,
X2= 0.020, P.0.05; Irs12/2, X2 = 0.805, P.0.05). Cox regres-
sion analysis on combined data from both independent female
studies (current vs. original study [12]) indicated that date of birth
(Z= 1.522, P.0.05), parental identity (Z= 0.313, P.0.05) or
experimental cohort (Z= 1.233, P.0.05) did not have any
significant impact on lifespan. However, the effect of genotype
on lifespan was highly significant (Z= 14.557, P,0.001). When
the mortality data from both studies were combined (Fig. 1B;
Table 1), median lifespan was again significantly higher
(X2= 16.480, P,0.0001) in female Irs12/2 mice compared to
WT controls. Maximum longevity was also increased in this
combined data set: the lifespan of the longest lived 10% of mice
was significantly greater (X2 = 5.629, P,0.05) in Irs12/2 mice
(1187631 days) relative to WT animals (973636 days). Median
lifespan was also significantly increased (X2= 5.059, P,0.05) in
male Irs12/2 mice relative to WT controls (Fig. 2; Table 2).
In conclusion, we replicate and validate our previous finding [12]
that global deletion of Irs1 induces a robust lifespan extension in
female mice. Therefore, we now clearly show that, in addition to the
GH deficient dwarf mice [17,18,19,20,21,22], female Irs12/2 mice
also show a highly consistent and repeatable lifespan extension
across distinct studies. In common with the Ames dwarf mouse
lifespan studies [17,18], the two separate lifespan studies in female
Irs12/2 mice were undertaken in the same vivarium, albeit at
different times. We suggest that replication of survival data, such as
ours and those of the GH dwarfs [17,18,19,20,21,22], will
significantly help increase confidence in exactly what genetically
modified mice are valid models of retarded aging [13,14]. In turn,
this confidence should focus time and resources on those
interventions that will ultimately help us to understand what
mechanisms underlie healthy aging in humans. It should be noted
that one additional limitation in mouse longevity studies is that they
are generally performed in a single genetic background, e.g.
C57BL/6. We suggest that it will be highly informative for future
studies to examine longevity in mice, such as Irs1 nulls, across
different genetic backgrounds.
We also show that, in contrast to our earlier study [12], a
completed and augmented lifespan study in male mice indicates
that median lifespan is extended in male Irs12/2 mice by ,16%.
This new finding suggests that the lack of any effect was probably
due to an incomplete and slightly underpowered earlier study in
males [12], with larger sample sizes undoubtedly helping to detect
relatively subtle changes between genotypes [23]. This robust
Figure 1. Female Irs12/2 mice are significantly long-lived.
Kaplan-Meier survival curves for female WT and Irs12/2 mice from this
current study (Solid lines; under husbandry conditions exactly as
previously described [12,16]) and our original study (Stippled lines; [12]).
Blue and red lines indicate WT and Irs12/2 mice respectively (A).
Kaplan-Meier survival curves for the combined data for female WT and
Irs12/2 mice from this current study and our original study ([12]). Blue
and red lines indicate WT and Irs12/2 mice respectively (B).
doi:10.1371/journal.pone.0016144.g001
Table 1. Comparative survival characteristics of female wild
type (WT) and Irs12/2 mice.
Genotype Median Mean Range N
Current study WT 789 782627 572–1019 16
Irs12/2 869 837664 257–1228 15
Original study WT 738 748632 343–1049 21
Irs12/2 971 950638 693–1207 14
Combined WT 760 763621 343–1049 37
Irs12/2 922 891639 257–1228 29
Lifespan is reported in days (6 s.e.m., where appropriate) for WT and Irs12/2
mice from this current study and our original study [12]. Combined =Combined
lifespan data derived from current study and original study. N = sample size.
doi:10.1371/journal.pone.0016144.t001
Figure 2. Male Irs12/2 mice are significantly long-lived. Kaplan-
Meier survival curves for male WT and Irs12/2 mice. Blue and red lines
indicate WT and Irs12/2 mice respectively.
doi:10.1371/journal.pone.0016144.g002
Lifespan Extension in Irs1 Null Mice
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lifespan extension across genders in Irs12/2 mice is consistent with
findings reported for other manipulations including dietary
restriction [24,25], rapamycin treatment [6] and GH/GH-
receptor deficiency [8,23], but is not seen in other sufficiently
powered longevity studies (e.g. [26]). We suggest that these new
findings indicate that global deletion of IRS1 is a ‘replicable and
robust phenomenon’ [13] that extends lifespan in both female and
male mice. Therefore, we suggest that this model can be used with
confidence to explore the mechanisms underlying healthy ageing
in mammals.
Materials and Methods
Ethics statement
All efforts were made to ameliorate suffering following previously
described husbandry protocols (see [12]). The experimental
procedures described were carried out following local animal
ethical committee review (University College London, London
UK.), following guidelines set out by 1986 UKHomeOffice Animal
Procedures Act under the Home Office Licence PPL70/6648.
Animal husbandry
Mice were maintained under exactly the same experimental
conditions and protocols as previously described [12,16,26]. In
brief, Irs12/2 and wild-type (WT; Irs1+/+) control littermates were
generated from heterozygote parents maintained on a C57BL/6
background following 10 backcrosses. Mice were housed in groups
of three to eight same-sex littermates at,22uC and on a 12-h light/
dark cycle (lights on from 0700–2100hrs) under specific pathogen-
free conditions [12,16,26]. Mice had ad libitum access to chow [2018
Teklad Global (5% fat, 18% protein, 57% carbohydrate, and 20%
other components) Rodent Diet; Harlan Teklad, Bicester, Oxford-
shire, UK] and water. Kaplan-Meier survival curves were
constructed using known birth and death dates (see [12,16,26])
and the log-rank test used to evaluate statistical differences between
genotypes. Cox regression analysis was employed to determine
whether date of birth, parental identity, genotype or experimental
cohort (experiment 1 [12] or current experiment) influenced
lifespan significantly in female mice. Maximum life span was
calculated as mean age of the oldest 10% of mice per genotype. The
three Irs12/2 male mice that were alive and censored at 756, 756
and 828 days of age in the original study [12] lived until 995, 933
and 1192 days of age respectively. The 2 WT control males alive
and censored at 756 and 993 days of age in the original study [12]
lived until 968 and 1042 days of age respectively. The age at death
of the two additional Irs12/2 male littermates used in this current
study were 763 and 1051 days of age and their WT control
littermates were 734 and 736 days of age.
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